​

CAMP4 Therapeutics Stock (NASDAQ:CAMP)

ForecastRevenueOwnershipFinancialsChart
CAMP4 Therapeutics by TradingView

Previous Close

$6.05

52W Range

$1.30 - $7.75

50D Avg

$4.78

200D Avg

$3.27

Market Cap

$118.95M

Avg Vol (3M)

$254.42K

Beta

0.36

Div Yield

-

CAMP Company Profile

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

55

IPO Date

Oct 11, 2024

Website

CAMP Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceFeb 23Feb 22Feb 21
Application Subscriptions And Other Services$106.07M$112.92M$115.10M
Product$188.88M$182.92M$193.49M

Fiscal year ends in Dec 25 | Currency in USD

CAMP Financial Summary

Dec 25Dec 24Nov 23
Revenue-$652.00K$350.00K
Operating Income$-52.55M$-53.09M$-51.88M
Net Income$-80.40M$-51.79M$-49.29M
EBITDA$-52.55M$-51.39M$-50.20M
Basic EPS$-2.65$-2.66$-4.07
Diluted EPS$-2.65$-2.66$-4.07

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q3 24Jan 09, 24 | 6:33 PM
Q2 24Oct 05, 23 | 6:53 PM
Q1 24Jul 10, 23 | 7:24 PM

Peer Comparison

TickerCompany
HYFTMindWalk Holdings Corp.
QNCXQuince Therapeutics, Inc.
RPTXRepare Therapeutics Inc.
ALXOALX Oncology Holdings Inc.
PMVPPMV Pharmaceuticals, Inc.
BMEABiomea Fusion, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
ATYRaTyr Pharma, Inc.
VXRTVaxart, Inc.
UNCYUnicycive Therapeutics, Inc.